Inventor · disambiguated record
Qiyue Hu
Also filed as: HU QIYUE
24 granted patents·17 pending applications·65 citations·filing 2003–2025
94Inventor score
Files withJIANGSU HENGRUI MEDICINE CO28PFIZER5SUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD2Shanghai hengrui pharmaceutical co ltd2AGOURON PHARMA1
Top patents by PatentIndex Score
41 records- 0194US10905743B2Interleukin 15 protein complexJIANGSU HENGRUI MEDICINE CO·Filed 2015·Granted Feb 2, 2021·9 cites·10 claims
- 0291US11717559B2Interleukin 15 protein complex and use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2020·Granted Aug 8, 2023·2 cites·15 claims
- 0390US12258394B2IL-5 antibody, antigen binding fragment thereof, and medical application thereforJIANGSU HENGRUI MEDICINE CO·Filed 2022·Granted Mar 25, 2025·1 cites·13 claims
- 0486US9951077B2Aminopyridazinone compounds as protein kinase inhibitorsETERNITY BIOSCIENCE INC·Filed 2014·Granted Apr 24, 2018·9 cites·3 claims
- 0586US7468375B2Inhibitors of the HIV integrase enzymePFIZER·Filed 2005·Granted Dec 23, 2008·12 cites·20 claims
- 0684US10323037B2Aminopyridazinone compounds as protein kinase inhibitorsJIANGSU HENGRUI MEDICINE CO·Filed 2018·Granted Jun 18, 2019·4 cites·31 claims
- 0784US7368571B2HIV-Integrase inhibitors, pharmaceutical compositions and methods for their usePFIZER·Filed 2006·Granted May 6, 2008·4 cites·2 claims
- 0883US10815304B2PD-L1 antibody, antigen-binding fragment thereof and medical application thereofSUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD·Filed 2016·Granted Oct 27, 2020·3 cites·25 claims
- 0981US11359021B2PD-L1 antibody, antigen-binding fragment thereof, and pharmaceutical use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2019·Granted Jun 14, 2022·2 cites·20 claims
- 1078US11365247B2IL-5 antibody, antigen binding fragment thereof, and medical application thereforJIANGSU HENGRUI MEDICINE CO·Filed 2018·Granted Jun 21, 2022·1 cites·12 claims
- 1178US11117898B2Pyrazolo-heteroaryl derivative, preparation method and medical use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2017·Granted Sep 14, 2021·3 cites·23 claims
- 1277US7135482B2HIV-integrase inhibitors, pharmaceutical compositions, and methods for their useAGOURON PHARMA·Filed 2003·Granted Nov 14, 2006·7 cites·7 claims
- 1376US9637484B2Cycloalkyl acid derivative, preparation method thereof, and pharmaceutical application thereofShanghai hengrui pharmaceutical co ltd·Filed 2014·Granted May 2, 2017·5 cites·20 claims
- 1473US11535633B2Fused tricyclic heterocycle compounds and therapeutic uses thereofJIANGSU HENGRUI MEDICINE CO·Filed 2019·Granted Dec 27, 2022·2 cites·33 claims
- 1569US11981733B2LAG-3 antibody, antigen-binding fragment thereof, and pharmaceutical application thereofJIANGSU HENGRUI MEDICINE CO·Filed 2021·Granted May 14, 2024·0 cites·20 claims
- 1669US11525005B2Anti-CD40 antibody, antigen binding fragment thereof and medical use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2018·Granted Dec 13, 2022·1 cites·25 claims
- 1768US2025333494A1Il-5 antibody, antigen binding fragment thereof, and medical application thereforJIANGSU HENGRUI MEDICINE CO·Filed 2025·Application pending·0 cites
- 1864US2025270303A1Anti-abeta antibody, antigen-binding fragment thereof and application thereofJIANGSU HENGRUI MEDICINE CO·Filed 2025·Application pending·0 cites
- 1963US2008221154A1Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their usePFIZER·Filed 2008·Application pending·0 cites
- 2062US12325741B2Anti-Aβ antibodies and antigen-binding fragments thereofJIANGSU HENGRUI MEDICINE CO·Filed 2019·Granted Jun 10, 2025·0 cites·10 claims
- 2162US11155617B2LAG-3 antibody, antigen-binding fragment thereof, and pharmaceutical application thereofJIANGSU HENGRUI MEDICINE CO·Filed 2017·Granted Oct 26, 2021·0 cites·21 claims
- 2262US2021380593A1Pyrazolo-heteroaryl derivative, preparation method and medical use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2021·Application pending·0 cites
- 2359US11780923B2PD-L1 antibody, antigen-binding fragment thereof and medical application thereofSUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD·Filed 2020·Granted Oct 10, 2023·0 cites·23 claims
- 2458US2024392020A1Antigen-binding moleculeJIANGSU HENGRUI PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 2555US2023101735A1Anti-trop-2 antidody-exatecan analog conjugate and medical use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2021·Application pending·0 cites
- 2654US7692014B2Inhibitors of the HIV integrase enzymePFIZER·Filed 2005·Granted Apr 6, 2010·0 cites·4 claims
- 2754US2022153853A1Bispecific proteinJIANGSU HENGRUI MEDICINE CO·Filed 2019·Application pending·0 cites
- 2854US2022056094A1Human interleukin-2 variant or derivative thereofJIANGSU HENGRUI MEDICINE CO·Filed 2019·Application pending·0 cites
- 2953US11512129B2TIGIT antibody, antigen-binding fragment thereof, and medical use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2018·Granted Nov 29, 2022·0 cites·19 claims
- 3053US2023120270A1New polypeptide complexJIANGSU HENGRUI MEDICINE CO·Filed 2021·Application pending·0 cites
- 3151US10793643B2PCSK9 antibody, antigen-binding fragment thereof, and medical application thereofJIANGSU HENGRUI MEDICINE CO·Filed 2016·Granted Oct 6, 2020·0 cites·24 claims
- 3248US2022220218A1Anti-cd73 antibody, antigen-binding fragment thereof and application thereofJIANGSU HENGRUI MEDICINE CO·Filed 2019·Application pending·0 cites
- 3345US2020347130A1CD96 Antibody, Antigen-Binding Fragment and Pharmaceutical use ThereofJIANGSU HENGRUI MEDICINE CO·Filed 2018·Application pending·0 cites
- 3443US2023144203A1Drug conjugate of eribulin derivative, preparation method therefor and application thereof in medicineSHANGHAI SENHUI MEDICINE CO LTD·Filed 2021·Application pending·0 cites
- 3543US2022056044A1Tricyclic compounds as sting agonists, and preparation methods and medicinal uses thereofJIANGSU HENGRUI MEDICINE CO·Filed 2019·Application pending·0 cites
- 3642US2020369774A1Il-6r antibody and antigen binding fragment thereof and medical useJIANGSU HENGRUI MEDICINE CO·Filed 2018·Application pending·0 cites
- 3739US10398689B2Benzopiperidine derivative, preparation method thereof and medical use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2016·Granted Sep 3, 2019·0 cites·24 claims
- 3839US2020270365A1Pcsk9 antibody, antigen-binding fragment thereof, and medical uses thereofJIANGSU HENGRUI MEDICINE CO·Filed 2016·Application pending·0 cites
- 3939US2010137283A1Inhibitors of the hiv integrase enzymePFIZER·Filed 2010·Application pending·0 cites
- 4037US2019315886A1Thrombin antibody, antigen-binding fragment and pharmaceutical use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2017·Application pending·0 cites
- 4133US10081629B2Amide derivatives and pharmaceutically acceptable salts thereof, preparation method thereof and medicinal application thereofShanghai hengrui pharmaceutical co ltd·Filed 2015·Granted Sep 25, 2018·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Qiyue Hu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →